Literature DB >> 27600500

Mast cells are not associated with systemic insulin resistance.

Elisa Einwallner1, Florian W Kiefer2, Giuseppe Di Caro3, Michael Orthofer4, Nadine Witzeneder1, Gregor Hörmann1, Bianca Itariu2, Maximilian Zeyda2, Josef M Penninger4, Thomas M Stulnig2, Harald Esterbauer1, Jelena Todoric5,6.   

Abstract

BACKGROUND: Infiltration of white adipose tissue (WAT) by inflammatory cells in obesity is considered to be a key event in the development of insulin resistance. Recently, mast cells (MCs) have been identified as new players in the pathogenesis of obesity. We aimed to investigate the relationship between MCs and various inflammatory markers in serum and WAT and to determine the role of MCs in the aetiology of insulin resistance.
MATERIALS AND METHODS: Gene expression was measured in WAT from 20 morbidly obese patients and 20 nonobese control subjects. Homoeostasis Model of Assessment-Insulin Resistance (HOMA-IR) was used to estimate insulin sensitivity. In addition, wild-type and mast cell-deficient mice were fed a high-fat or low-fat diet to study mast cell influence on inflammatory cell polarization in WAT and overall metabolic changes.
RESULTS: WAT levels of MC-specific TPSb2 transcript were increased in obesity and significantly positively correlated with TNF, CCL2, CCL5 and CD68 gene expression levels in our study subjects after adjustment for sex, age and BMI. Accordingly, MC deficiency abrogated increase in expression of pro-inflammatory M1 macrophage marker genes in mouse WAT upon high-fat diet feeding. However, MCs accumulated in obese human WAT independent of insulin resistance and systemic changes in inflammatory mediators.
CONCLUSIONS: Our results suggest that MCs contribute to the local pro-inflammatory state within WAT in obesity but do not play a primary role in causing insulin resistance.
© 2016 Stichting European Society for Clinical Investigation Journal Foundation.

Entities:  

Keywords:  Inflammation; insulin resistance; mast cells; obesity

Mesh:

Substances:

Year:  2016        PMID: 27600500     DOI: 10.1111/eci.12675

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  6 in total

Review 1.  Microenvironment of Immune Cells Within the Visceral Adipose Tissue Sensu Lato vs. Epicardial Adipose Tissue: What Do We Know?

Authors:  Martin Klein; Ivan Varga
Journal:  Inflammation       Date:  2018-08       Impact factor: 4.092

2.  Higher Mast Cell Accumulation in Human Adipose Tissues Defines Clinically Favorable Obesity Sub-Phenotypes.

Authors:  Nir Goldstein; Yarden Kezerle; Yftach Gepner; Yulia Haim; Tal Pecht; Roi Gazit; Vera Polischuk; Idit F Liberty; Boris Kirshtein; Ruthy Shaco-Levy; Matthias Blüher; Assaf Rudich
Journal:  Cells       Date:  2020-06-20       Impact factor: 6.600

3.  Cytometric analysis of adipose tissue reveals increments of adipocyte progenitor cells after weight loss induced by bariatric surgery.

Authors:  Jesús García-Rubio; Josefa León; Anaïs Redruello-Romero; Esther Pavón; Antonio Cozar; Francisco Tamayo; Mercedes Caba-Molina; Javier Salmerón; Ángel Carazo
Journal:  Sci Rep       Date:  2018-10-12       Impact factor: 4.379

Review 4.  Metabolic Inflammation and Insulin Resistance in Obesity.

Authors:  Huaizhu Wu; Christie M Ballantyne
Journal:  Circ Res       Date:  2020-05-21       Impact factor: 17.367

Review 5.  Mast Cells in Diabetes and Diabetic Wound Healing.

Authors:  Jie Dong; Lihong Chen; Ying Zhang; Navin Jayaswal; Ikram Mezghani; Weijie Zhang; Aristidis Veves
Journal:  Adv Ther       Date:  2020-09-15       Impact factor: 3.845

6.  Molecular characterization of the human kidney interstitium in health and disease.

Authors:  Daria Barwinska; Tarek M El-Achkar; Ricardo Melo Ferreira; Farooq Syed; Ying-Hua Cheng; Seth Winfree; Michael J Ferkowicz; Takashi Hato; Kimberly S Collins; Kenneth W Dunn; Katherine J Kelly; Timothy A Sutton; Brad H Rovin; Samir V Parikh; Carrie L Phillips; Pierre C Dagher; Michael T Eadon
Journal:  Sci Adv       Date:  2021-02-10       Impact factor: 14.136

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.